HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 297 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,102,000 | -68.8% | 130,000 | -60.0% | 0.85% | -71.2% |
| Q2 2022 | $25,946,000 | -26.6% | 325,299 | -3.1% | 2.95% | -15.4% |
| Q1 2022 | $35,333,000 | -23.2% | 335,837 | -21.0% | 3.49% | +13.9% |
| Q4 2021 | $46,011,000 | -10.6% | 425,000 | -9.6% | 3.06% | -15.3% |
| Q3 2021 | $51,484,000 | +4.7% | 470,000 | -10.5% | 3.61% | +8.3% |
| Q2 2021 | $49,161,000 | -10.2% | 525,000 | -11.8% | 3.34% | -12.6% |
| Q1 2021 | $54,764,000 | +24.8% | 595,000 | -0.8% | 3.82% | +6.6% |
| Q4 2020 | $43,890,000 | -18.7% | 600,000 | -13.7% | 3.58% | -25.4% |
| Q3 2020 | $53,988,000 | +29.5% | 695,000 | -7.3% | 4.80% | +6.6% |
| Q2 2020 | $41,685,000 | +40.7% | 750,000 | -25.0% | 4.50% | +8.5% |
| Q1 2020 | $29,620,000 | +5.6% | 1,000,000 | +29.0% | 4.15% | +35.0% |
| Q4 2019 | $28,055,000 | +0.5% | 775,000 | -24.4% | 3.07% | -12.1% |
| Q3 2019 | $27,911,000 | – | 1,025,000 | – | 3.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |